Petr Bradna

Petr Bradna

Auto-generated profile, based on publicly available information

Petr Bradna

12nd Department of Internal Medicine-Gastroenterology, Charles University in Prague, Medical Faculty and University Hospital in Hradec Kralove

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2013 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
ITIlja Tacheci
Ilja Tacheci
PBPetr Bradna
Petr Bradna
TDTomáš Douda
Tomáš Douda
DBDrahomíra Baštecká
Drahomíra Baštecká
MKMarcela Kopáčová
Marcela Kopáčová
JBJan Bures
Jan Bures
Background. The purpose of study was to evaluate the diagnostic yield of capsule endoscopy for NSAID-induced enteropathy and clinical, laboratory, and endoscopic characteristics of disease in patients with rheumatoid arthritis.Methods. 37 rheumatoid arthritis patients (30 women; mean age 55) treated with NSAIDs (>1 month), presented with anaemia and/or positive faecal occult blood testing, entered the study and underwent capsule endoscopy (EndoCapsule; Olympus), laboratory tests, and filled in questionnaires.Results. The prevalence of NSAID-induced enteropathy diagnosed by capsule endoscopy was 68% (25/37), classified as mild (red spots or erosions) in 18 (49%), moderate (10–20 erosions) in 4 (11%), and severe enteropathy (>20 erosions or ulcers) in 3 (8%) patients. We did not find statistically significant relationship between the enteropathy and gender, age, haemoglobin, leukocytes, albumin and CRP, or dyspepsia. The difference between subgroups of NSAIDs according to the COX specificity was not statistically significant.Conclusions. Capsule endoscopy is a highly accurate noninvasive method for evaluation of NSAID-induced enteropathy. It was revealed in a substantial section of the patients with rheumatoid arthritis and occult gastrointestinal bleeding, mostly classified as mild damage. No simple clinical or laboratory markers of the presence or severity of NSAID-induced enteropathy were recognised. This trial is registered withDRKS00004940.

25 January 2015 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
TSTomáš Soukup
Tomáš Soukup
MDMartin Doležal
Martin Doležal
PPPetr Pavek
Petr Pavek
JNJana Nekvindova
Jana Nekvindova
IBIvana Baranová
Ivana Baranová
JVJiri Vlcek
Jiri Vlcek

28 August 2015 in Rheumatology
Verified
Journal Article
Open access
PDF file
TSTomáš Soukup
Tomáš Soukup
RPRadek Pudil
Radek Pudil
KKKaterina Kubinova
Katerina Kubinova
LHLucie Hromadkova
Lucie Hromadkova
JDJaroslav Dusek
Jaroslav Dusek
JBJan Bures
Jan Bures
Objective. The early, simple and reliable detection of pulmonary arterial hypertension (PAH) in SSc (DETECT) study described a new algorithm for early detection of PAH in patients with SSc. The aim of this retrospective, single-centre, cross-sectional study was to apply a modified DETECT calculator in patients with SSc in the East Bohemian region, Czech Republic, to assess the risk of PAH and to compare these results with PAH screening based on the European Society of Cardiology/European Respiratory Society (ESC/ERS) 2009 guidelines. Methods. Sixty patients were recruited with a diagnosis of SSc (according to ACR criteria), aged 27–78 years. A modified DETECT algorithm using the modified parameter of (1.4 × right ventricle diameter)2 in place of right atrium area was applied to all patients. Right heart catheterization (RHC) was performed in all patients with an estimated (by echocardiography) increased systolic pulmonary artery pressure ≥50 mm Hg in accordance with the ESC/ERS guidelines; however, RHC was not performed in patients solely recommended for RHC using the modified DETECT algorithm. Results. Using the modified DETECT calculator, 24/58 (41.4%) patients were recommended for RHC, compared with 14/58 (24.1%) when applying the ESC/ERS 2009 guidelines. PAH was diagnosed in 7/58 (12.1%) patients. During follow-up, PAH was diagnosed in six patients. Of these, four were modified DETECT score–positive for 2 years and all for 1 year before PAH diagnosis. Conclusion. The modified DETECT algorithm detects all patients with PAH diagnosed according to ECS/ERS 2009 guidelines and RHC. Data of the 2-year follow-up indicate a possible positive predictive role for the modified DETECT calculator.

22 August 2016 in Rheumatology International
Verified
Journal Article
Open access
PDF file
ITIlja Tacheci
Ilja Tacheci
PBPetr Bradna
Petr Bradna
TDTomáš Douda
Tomáš Douda
DBDrahomíra Baštecká
Drahomíra Baštecká
MKMarcela Kopáčová
Marcela Kopáčová
JBJan Bures
Jan Bures
The goal of this prospective study was to assess non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy in patients with rheumatoid arthritis (RA) or osteoarthritis (OA) by means of non-invasive wireless capsule enteroscopy. A total of 143 patients (74 with RA, 69 with OA) treated with NSAIDs (>1 month) and 42 healthy volunteers were included. All subjects underwent capsule endoscopy, laboratory tests and filled in questionnaires. The severity of small bowel injury was graded as: mild (red spots or sporadic erosions), moderate (10–20 erosions) or severe (>20 erosions or ulcers). Capsule endoscopy identified small bowel lesions in 44.8 % of patients (mild 36.4 %, moderate 3.5 % and severe in 4.9 %). Mild non-specific lesions were found in 11.9 % healthy volunteers. There was a significantly higher prevalence of enteropathy in RA (56.8 %) compared to OA (31.9 %, p < 0.01). A significant difference between NSAID users (RA and OA) with and without enteropathy was observed in erythrocytes (p < 0.01), the leucocyte count (p < 0.05), haemoglobin (p < 0.05), haematocrit (p < 0.05), serum albumin (p < 0.01) and erythrocyte sedimentation rate (p < 0.05). No relationship was found between enteropathy and dyspepsia, gender or age. NSAID therapy is associated with a significant risk of small bowel injury. The risk is significantly higher in RA patients suggesting a possible influence of the underlying disease.Trial registration number: DRKS00004940.

1 January 2012 in Acta Medica (Hradec Kralove, Czech Republic)
Verified
Journal Article
Open access
PDF file
MTMarian Tošovský
Marian Tošovský
PBPetr Bradna
Petr Bradna
JLJan Laco
Jan Laco
MPMiroslav Podhola
Miroslav Podhola
TSTomáš Soukup
Tomáš Soukup
JBJan Brožík
Jan Brožík
Acta Medica is a scientific journal of Charles University in Prague, Faculty of Medicine in Hradec Kralove

9 February 2010 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
JTJan Toms
Jan Toms
TSTomáš Soukup
Tomáš Soukup
PBPetr Bradna
Petr Bradna
ZHZbynek Hrncir
Zbynek Hrncir